Responses to alloantigens and transplant rejection Immune response against grafted cells tissues, or organs CH15 Ch16 Immune modulators

Embed Size (px)

Citation preview

  • Slide 1
  • Responses to alloantigens and transplant rejection Immune response against grafted cells tissues, or organs CH15 Ch16 Immune modulators
  • Slide 2
  • Chapter 15 Transplantation of tissues and organs The immune system Third edition Peter Parham (2009)
  • Slide 3
  • Identity of transplantation antigens Type and prevention of immune response in rejection of solid organs Bone marrow transplantation
  • Slide 4
  • Donor
  • Slide 5
  • Autograft Isograft Allograft Xenograft MHC Ag Class I Class II Major histocompatibility complex (MHC) Identity of transplantation antigens
  • Slide 6
  • Hyperacute rejection (within 24h) Acute rejection (first few weeks) Chronic rejection (months - years) Type and prevention of immune response in rejection of solid organs
  • Slide 7
  • Hyperacute rejection C, blood clotting Pre-existing Ab (e.g. Anti-MHC, A/B/O) Repeated blood transfusions Repeated pregnancies Previous graft Immediate graft death
  • Slide 8
  • Hyperacute rejection
  • Slide 9
  • Cell-mediated immunity (CMI) Acute rejection Th1 response Macrophages (Type IV hypersensitivity) CTLs Allogeneic T cells The frequency of T cells specific for any non-self MHC molecules is relatively high Cross reactivity (first few weeks) MHC polymorphism
  • Slide 10
  • Cross reactivity Self High affinity to non-self MHC Ag Affinity High frequency of allogeneic T cells
  • Slide 11
  • Donor DC Acute rejection Anti-CD3
  • Slide 12
  • In vitro mixed lymphocyte reaction (MLR) APC: donorT: recipient Target: donor
  • Slide 13
  • Minor histocompatibility Ag HLA matching Polymorphic Ag (proteins that differ in amino acid sequence between individuals)
  • Slide 14
  • Donor Recipient Donor Two ways of allo-Ag recognition
  • Slide 15
  • Chronic rejection (months - years) FcR Infiltration Fibrosis Atrophy
  • Slide 16
  • Cancer therapy Genetic diseases of blood cells Chemotherapy Repopulation Reconstitution of the patients immune system and also their red cells and platelets Intravenous infusion Bone marrow transplantation
  • Slide 17
  • T cells : thymus MHC restriction Positive selection 17
  • Slide 18
  • Hematopoiesis MHC a MHC b MHC axb APC 18
  • Slide 19
  • Bone marrow-derived APC Thymic non-lymphoid stroma Bone marrow chimera Blood type The more HLA allotypes they share, the better it works
  • Slide 20
  • HLA-haploidentical family members
  • Slide 21
  • Engraftment: Colonization of HSC in the bone of recipient Myeloablative therapy Niche Enrichment
  • Slide 22
  • Graft-versus-host disease (GVHD) Recipient DC Stringent T-cell depletion
  • Slide 23
  • Tissue inflammation Cytokine storm Activation of allogeneic T cells Acute GVHD: First few months Graft-versus-leukemia effect Graft-versus-tumor effect